Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome 2024-04-03 11:14
I-Mab Announces Closing of the Divestiture of Business Operations in China 2024-04-03 04:01
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 2024-04-02 23:00
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH 2024-04-02 20:00
Origin Agritech Provides First Half Revenue Forecast and Updates Advancements in Hybrids and GMO Development 2024-04-02 19:30
CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO 2024-04-02 17:33
European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers 2024-04-02 14:16
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status 2024-04-02 13:00
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY 2024-04-02 11:31
Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS 2024-04-02 10:30
Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023 2024-04-02 00:38
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification 2024-04-01 21:00
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones 2024-04-01 21:00
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development 2024-04-01 20:00
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
Hyosung TNC Invests $1 Billion in Future "Bio" Business 2024-04-01 08:18
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
1 4 5 6 7 8 412